New York State Common Retirement Fund’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-59,354
| Closed | -$1.95M | – | 3585 |
|
|
2022
Q2 | $1.95M | Sell |
59,354
-88
| -0.1% | -$2.78K | ﹤0.01% | 1679 |
|
|
2022
Q1 | $1.56M | Buy |
59,442
+26
| +0% | +$635 | ﹤0.01% | 1873 |
|
|
2021
Q4 | $1.41M | Buy |
59,416
+3,937
| +7% | +$97.2K | ﹤0.01% | 1956 |
|
|
2021
Q3 | $1.39M | Buy |
55,479
+300
| +0.5% | +$7.64K | ﹤0.01% | 1959 |
|
|
2021
Q2 | $1.43M | Buy |
55,179
+293
| +0.5% | +$7.97K | ﹤0.01% | 2053 |
|
|
2021
Q1 | $1.41M | Hold |
54,886
| – | – | ﹤0.01% | 1970 |
|
|
2020
Q4 | $1.1M | Hold |
54,886
| – | – | ﹤0.01% | 2007 |
|
|
2020
Q3 | $940K | Hold |
54,886
| – | – | ﹤0.01% | 1936 |
|
|
2020
Q2 | $1.2M | Hold |
54,886
| – | – | ﹤0.01% | 1774 |
|
|
2020
Q1 | $1.27M | Buy |
54,886
+24,586
| +81% | +$715K | ﹤0.01% | 1623 |
|
|
2019
Q4 | $1M | Sell |
30,300
-4,300
| -12% | -$138K | ﹤0.01% | 1951 |
|
|
2019
Q3 | $1.1M | Hold |
34,600
| – | – | ﹤0.01% | 1948 |
|
|
2019
Q2 | $889K | Hold |
34,600
| – | – | ﹤0.01% | 2079 |
|
|
2019
Q1 | $878K | Buy |
34,600
+3,000
| +9% | +$89.5K | ﹤0.01% | 2031 |
|
|
2018
Q4 | $1.07M | Sell |
31,600
-4,300
| -12% | -$140K | ﹤0.01% | 1870 |
|
|
2018
Q3 | $1.28M | Hold |
35,900
| – | – | ﹤0.01% | 1950 |
|
|
2018
Q2 | $1.24M | Buy |
35,900
+3,100
| +9% | +$109K | ﹤0.01% | 1987 |
|
|
2018
Q1 | $1.1M | Sell |
32,800
-7,659
| -19% | -$242K | ﹤0.01% | 1971 |
|
|
2017
Q4 | $1.55M | Sell |
40,459
-11,226
| -22% | -$448K | ﹤0.01% | 1790 |
|
|
2017
Q3 | $1.94M | Sell |
51,685
-30,333
| -37% | -$1.07M | ﹤0.01% | 1658 |
|
|
2017
Q2 | $3.06M | Buy |
82,018
+5,571
| +7% | +$201K | ﹤0.01% | 1484 |
|
|
2017
Q1 | $3M | Buy |
76,447
+486
| +0.6% | +$18.2K | ﹤0.01% | 1466 |
|
|
2016
Q4 | $2.64M | Sell |
75,961
-83,467
| -52% | -$3.28M | ﹤0.01% | 1539 |
|
|
2016
Q3 | $6.26M | Buy |
159,428
+40,284
| +34% | +$1.61M | 0.01% | 1128 |
|
|
2016
Q2 | $4.5M | Buy |
119,144
+86,344
| +263% | +$2.89M | 0.01% | 1273 |
|
|
2016
Q1 | $1.26M | Buy |
32,800
+1,100
| +3% | +$41K | ﹤0.01% | 1823 |
|
|
2015
Q4 | $1.52M | Sell |
31,700
-52,894
| -63% | -$2.45M | ﹤0.01% | 1749 |
|
|
2015
Q3 | $3.34M | Sell |
84,594
-64,624
| -43% | -$2.75M | 0.01% | 1367 |
|
|
2015
Q2 | $6.35M | Sell |
149,218
-12,046
| -7% | -$480K | 0.01% | 1209 |
|
|
2015
Q1 | $6.37M | Sell |
161,264
-51,811
| -24% | -$1.91M | 0.01% | 1083 |
|
|
2014
Q4 | $7.68M | Buy |
213,075
+41,100
| +24% | +$1.38M | 0.01% | 986 |
|
|
2014
Q3 | $5.08M | Buy |
171,975
+107,675
| +167% | +$2.97M | 0.01% | 1189 |
|
|
2014
Q2 | $1.62M | Sell |
64,300
-3,000
| -4% | -$74.2K | ﹤0.01% | 1739 |
|
|
2014
Q1 | $1.74M | Hold |
67,300
| – | – | ﹤0.01% | 1692 |
|
|
2013
Q4 | $1.51M | Hold |
67,300
| – | – | ﹤0.01% | 1717 |
|
|
2013
Q3 | $954K | Hold |
67,300
| – | – | ﹤0.01% | 1764 |
|
|
2013
Q2 | $919K | Buy |
+67,300
| New | +$917K | ﹤0.01% | 1657 |
|
Other funds holding NTUS
New York State Common Retirement Fund's NTUS Position: Q3 2022 in Review
New York State Common Retirement Fund sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 59,354 shares — an estimated $1.95M sold.
New York State Common Retirement Fund first reported a position in NTUS in Q2 2013 and held it in 37 quarters. The position peaked at $7.68M in Q4 2014. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- New York State Common Retirement Fund reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- New York State Common Retirement Fund sold 59,354 Natus Medical Inc shares in Q3 2022, an estimated $1.95M.
- New York State Common Retirement Fund first reported a position in Natus Medical Inc in Q2 2013 and held it in 37 quarters.
- New York State Common Retirement Fund's Natus Medical Inc position peaked at $7.68M in Q4 2014.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.